NCT01068522

Brief Summary

People who survive severe traumatic brain injury (TBI) live with profound cognitive impairments that alter their developmental course and define their future possibilities. Worldwide, TBI is the leading cause of death and disability among children and adolescents (Murgio, 2000). In the United States, the annual incidence of TBI is six times greater than that of multiple sclerosis, HIV/AIDS, spinal cord injury, and breast cancer combined \[Centers for Disease Control, American Cancer Society, National Multiple Sclerosis Society\]. The burden of TBI may be even greater in developing countries, due to civil unrest and war, and to the absence of mandated prevention such as seat belt laws. The long-term objective of the investigators' research group is to improve outcomes for survivors of TBI in Latin America. To that end, the investigators have created a structure for professionals and institutions involved in the treatment of TBI to generate research; to facilitate education, standardization, certification, the dissemination of information and resources; and to foster the development of evidence-based guidelines. The structure is the Latin American Brain Injury Consortium (LABIC).

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
324

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Jul 2007

Longer than P75 for phase_3

Geographic Reach
2 countries

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

February 11, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 15, 2010

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

November 1, 2012

Status Verified

October 1, 2012

Enrollment Period

4.8 years

First QC Date

February 11, 2010

Last Update Submit

October 31, 2012

Conditions

Keywords

Intracranial pressureIntracranial pressure monitoringHead injury

Outcome Measures

Primary Outcomes (1)

  • In a randomized controlled trial in 3 trauma centers in Bolivia, test the effect on outcomes of management of severe TBI guided by information from ICP monitors vs. a standard empiric protocol.

    6 months

Study Arms (2)

ICP monitoring

EXPERIMENTAL

Care based upon intracranial pressure.

Device: Parenchymal Intracranial pressure monitor

Usual Care

ACTIVE COMPARATOR

Treatment based on clinical and imaging without intracranial pressure monitoring.

Other: Treatment based on clinical and imaging observations

Interventions

Treatment based on readings from Parenchymal intracranial pressure monitor.

Also known as: Integra Life Sciences Camino Intracranial Monitor
ICP monitoring

Treatment based on clinical and imaging observations.

Usual Care

Eligibility Criteria

Age13 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • admission to study hospital within 24 hours of injury
  • closed head trauma
  • Glasgow Coma Scale (GCS) \< 8 on admission or if intubated, GCS Motor \< 5, within first 48 hours after injury
  • No foreign object in brain parenchyma
  • Randomized:
  • within 24 hours of injury \[for patients with GCS \< 8 on admission\] or
  • within 24 hours of deterioration \[patients deteriorating to GCS \< 8 within 48 hours of injury\]
  • Age \> 12

You may not qualify if:

  • GCS of 3 with bilateral fixed and dilated pupils and/or decision to not actively treat prior to enrolment into study
  • No beds available in ICU
  • No ICP monitor available
  • Pregnancy
  • Prisoner
  • No consent
  • Non-survivable injury
  • Other (e.g., Pre-injury life expectancy under 1 year)
  • Pre-existing neurological disability that would not allow follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Hospital Viedma

Cochabamba, Bolivia

Location

Hospital Japones

Santa Cruz de la Sierra, Bolivia

Location

Hospital San Juan de Dios

Santa Cruz de la Sierra, Bolivia

Location

Hospital San Juan de Dios

Tarija, Bolivia

Location

Hospital de Especialidades Eugenio Espejo

El Ángel, Ecuador

Location

Hospital Luis Vernaza

Guayaquil, Ecuador

Location

Related Publications (1)

  • Chesnut RM, Temkin N, Carney N, Dikmen S, Rondina C, Videtta W, Petroni G, Lujan S, Pridgeon J, Barber J, Machamer J, Chaddock K, Celix JM, Cherner M, Hendrix T; Global Neurotrauma Research Group. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012 Dec 27;367(26):2471-81. doi: 10.1056/NEJMoa1207363. Epub 2012 Dec 12.

MeSH Terms

Conditions

Brain Injuries, TraumaticBrain InjuriesCraniocerebral Trauma

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Randall M Chesnut, MD

    University of Washington, Harborview Medical Center, Seattle, WA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2010

First Posted

February 15, 2010

Study Start

July 1, 2007

Primary Completion

April 1, 2012

Study Completion

March 1, 2013

Last Updated

November 1, 2012

Record last verified: 2012-10

Locations